• Cy5 maleimide for Protein Labeling and LLPS

  2026-09-09

  Cy5 maleimide enables cysteine-selective, far-red protein labeling for microscopy, readers, and condensate partitioning assays. This guide pairs a solvent-aware conjugation workflow with α-synuclein electrostatics findings while showing how to distinguish true molecular partitioning from dye-induced artifacts.

• Surface-Cleaned Black Phosphorus in Acute Kidney Injury

  2026-09-09

  A 2026 Theranostics study shows that hydrogen-reduced, surface-cleaned black phosphorus nanosheets can accumulate in injured kidneys, chelate labile iron, suppress ferroptosis, and reduce macrophage-driven inflammation. The work is notable because it connects nanomaterial surface chemistry with coordinated control of tubular oxidative injury and immune amplification, while also providing a multi-level framework for evaluating iron-dependent kidney damage.

• AZD1390: ATM Kinase Inhibitor for Radiosensitization

  2026-09-09

  AZD1390 is a potent ATM kinase inhibitor that suppresses DNA damage response signaling in cellular assays. Its nanomolar activity and radiation-enhanced effects support cancer research focused on glioblastoma radiosensitization, lung cancer models, and ATM-dependent checkpoint biology.

• H 89 2HCl in D2-MSN Signaling Assays

  2026-09-08

  H 89 2HCl enables controlled interrogation of PKA signaling without confusing kinase activity with cAMP production. This guide connects its assay profile with recent D2-MSN and autism-related circuit research, emphasizing interpretation, controls, and experimental boundaries.

• QNZ (EVP4593) NF-κB Research Workflows

  2026-09-07

  QNZ (EVP4593) combines nanomolar NF-κB pathway inhibition with practical applications in inflammatory signaling and Huntington’s disease research. This workflow-oriented guide covers dose finding, reporter and TNF-α validation, calcium-flux studies, solubility control, and troubleshooting for more reproducible results.

• Tomivosertib: MNK1 Inhibitor Workflow Guide

  2026-09-07

  Tomivosertib enables selective interrogation of MNK1/2-driven eIF4E phosphorylation in cancer, endothelial, neuronal, and metabolic models. This practical guide connects target-engagement assays with angiogenesis, apoptosis, chemotherapy-sensitization, and troubleshooting workflows.

• Erastin: A Practical Ferroptosis Inducer Workflow

  2026-09-05

  Build a controlled ferroptosis workflow with Erastin by combining genotype-aware cell selection, fresh DMSO preparation, orthogonal oxidative-stress readouts, and rescue controls. The approach supports both cancer biology research and mechanistic studies inspired by evidence linking ferroptosis to cisplatin-induced kidney injury.

• Flubendazole: Reliable Autophagy Assays

  2026-09-04

  Learn how Flubendazole (SKU B1759) can support better-controlled cell viability, proliferation, and cytotoxicity workflows. This scenario-based guide covers solvent handling, assay design, protocol parameters, metabolic confounding, and practical supplier selection.

• Proteinase K for DNA Prep and Protease Assays

  2026-09-04

  Proteinase K combines broad protein digestion with compatibility across detergents, EDTA, and DNA-preserving workflows. This guide shows how to use it for genomic DNA isolation, contaminant removal, assay controls, and troubleshooting informed by SARS-CoV-2 3CLpro inhibitor profiling.

• SmD2 Acetylation and PARP Inhibitor Sensitivity in HCC

  2026-09-03

  The reference study identifies acetylation-dependent control of the spliceosome protein SmD2 as a determinant of BRCA1/FANC cassette exon regulation and PARP inhibitor response in hepatocellular carcinoma. Its findings support a biomarker-led strategy in which SmD2 destabilization or HDAC2 inhibition may increase vulnerability to PARP inhibition, including in models that are not defined solely by BRCA loss.

• Pioglitazone PPARγ Agonist Workflows

  2026-09-03

  Pioglitazone connects PPARγ activation with measurable changes in metabolism, macrophage state, epithelial integrity, and neuroinflammatory signaling. This workflow-focused guide translates recent DSS colitis findings into practical cell and animal assay choices, formulation controls, and troubleshooting steps.

• NHE1, Olfr2, and Macrophage-Driven Atherosclerosis

  2026-09-02

  This study identifies macrophage sodium–hydrogen exchanger 1 (NHE1) as a downstream mediator linking octanal/Olfr2 signaling to calcium-dependent reactive oxygen species production, NLRP3 inflammasome activation, and atherosclerosis. Its combination of mouse experiments, macrophage models, pharmacological inhibition, RNA interference, and calcium chelation provides a mechanistic framework for interpreting lipid-peroxidation signals in vascular inflammation.

• Bergenin Targets γδT17 Cells in Psoriasis

  2026-09-02

  A 2026 Phytomedicine study identifies a mechanistic link between bergenin, PPARγ activation, PROX1 degradation, fatty acid oxidation, and IL-17A production in psoriasis. Its layered cellular, metabolic, ubiquitination, and chromatin analyses suggest a selective strategy for suppressing pathogenic γδT17 cells while highlighting important limits for translation beyond preclinical models.

• Activating p53Y220C Through Chemical Proximity

  2026-09-01

  The bioRxiv study reports TRAP-1, a small-molecule chemical inducer of proximity that brings mutant p53Y220C into a ternary complex with BRD4 and restores transcription of p53-responsive genes. Its matched negative-control strategy supports chemically induced proximity, rather than nonspecific compound activity, as the basis for p21 induction and growth inhibition in p53Y220C-expressing pancreatic cancer cell lines.

• MK-2206: Akt Pathway Workflows for Cancer Research

  2026-09-01

  Build cleaner Akt-targeted experiments with MK-2206 dihydrochloride, from phosphorylation checks to apoptosis and endothelial angiogenesis assays. This guide translates an extracellular-vesicle HCC study into practical pharmacologic validation workflows while emphasizing dosing, controls, solubility, and troubleshooting.

8603 records 6/574 page Previous Next First page 上5页 678910 下5页 Last page